Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer

Part of paid clinical trials in Los Angeles, California.

Sponsor
Massachusetts General Hospital
Study ID
NCT06427954
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Digital Health App — BEHAVIORAL
    access to a digital health app

Study Details

Multi-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.

Key Dates

Start date
Aug 6, 2024
Status verified
Nov 2024
Primary completion
Sep 30, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
250 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Active Comparator: THRIVE Digital Health App
    Patients assigned to the intervention will be provided a study-issued tablet computer from which they will access the THRIVE digital health app. Study staff will give intervention patients a comprehensive tutorial and detailed instructions regarding how to use the app. Tutorial sessions may be conducted in person during a clinic appointment, via telephone, and/or via Zoom videoconferencing. Participants will complete the intervention modules at their desired pace over approximately 10 weeks.
  • No Intervention: Usual Care
    Patients assigned to the usual care group will not receive the digital app but rather standard oncology care.

Primary Outcome Measure

Functional Assessment of Cancer Therapy - Lung (FACT-L) [ Time Frame: 12 weeks ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
University of California Los AngelesLos AngelesCalifornia90024
Anne Walling
[email protected]
Veteran Affairs Greater Los Angeles Health CareLos AngelesCalifornia90073
Anne Walling
[email protected]
Massachusetts General HospitalBostonMassachusetts02114
Jennifer Temel, MD
[email protected]
617-724-4000
Jennifer Temel, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
University of California Los Angeles· Los Angeles, CAVeteran Affairs Greater Los Angeles Health Care· Los Angeles, CAMassachusetts General Hospital· Boston, MA

Related Studies